Federico Mattioli
Ophthalmology · Houston, TXNPI 1861617458
Payments from drug & device makers
Across 175 payments — averaging $44.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$965
- Johnson & Johnson Surgical Vision, Inc.$753
- AbbVie$696
- Eyevance Pharmaceuticals LLC$654
- Tarsus Pharmaceuticals, Inc.$566
- Carl Zeiss Meditec USA, Inc.$497
- plus $4K from 21 others
What the payments were for
- Food & beverage$7,732100%
- Gifts$360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 6 | $965 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $753 |
| AbbVie(2 entities) | 19 | $696 |
| Eyevance Pharmaceuticals LLC | 36 | $654 |
| Tarsus Pharmaceuticals, Inc. | 13 | $566 |
| Carl Zeiss Meditec USA, Inc. | 5 | $497 |
| Beaver-visitec International, Inc. | 1 | $445 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 22 | $415 |
| Carl Zeiss Meditec, Inc. | 3 | $392 |
| Lumenis BE Inc | 1 | $343 |
| Biotissue Holdings Inc. | 11 | $318 |
| Rxsight Inc | 6 | $316 |
| Oyster Point Pharma, Inc. | 8 | $286 |
| Glaukos Corporation | 5 | $272 |
| Bausch & Lomb Americas Inc. | 3 | $149 |
| Shire North American Group Inc | 8 | $127 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Kala Pharmaceuticals, Inc. | 6 | $112 |
| Abbott | 1 | $81 |
| Alcon | 2 | $68 |
| Rayner Intraocular Lenses Limited | 2 | $41 |
| Tearlab Corp | 3 | $36 |
| Ziemer USA | 1 | $30 |
| Novartis | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Aerie Pharmaceuticals, Inc. | 1 | $22 |
| Sight Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VisuMax$591
- Tecnis IOL$423
- VUITY$353
- optilight$343
- XDEMVY$275
- RXSIGHT CONTACT LENS$163
- RXSIGHT INJECTOR CARTRIDGE$163
- RXSIGHT INJECTOR HANDPIECE$163
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$163
- LIGHT ADJUSTABLE LENS (LAL)$163
- Prokera$146
- AmnioGraft$146
- AmnioGuard$146
- Zerviate$134
- ARTEVO 800$134
- CALLISTO eye$134
- IOLMaster 700$134
- VERACITY SURGICAL$134
- Photrexa$133
- AMVUTTRA$125
How this compares
$7,769 in reported general payments places this provider in the 80th percentile of 1,355 ophthalmology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 13 | $333 |
| Ketorolac Tromethamine | 13 | $131 |
| Latanoprost | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Houston
- David BrownHouston$51.7M
- John MichelettiHouston$3.3M
- Michael CaplanHouston$1.4M
- Shaheen KavoussiHouston$1.3M
- Kevin JongHouston$1.2M
- Stephen SladeHouston$1.2M
- Rosa TangHouston$1.1M
- Zaina Al-MohtasebHouston$1.1M
- Fiaz ZamanHouston$1M
- Stephen PflugfelderHouston$788K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.